查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1992183

支氣管鏡切片檢查器械市場：按技術、產品類型、手術類型、應用和最終用戶分類－2026-2032年全球市場預測

Bronchoscopic Biopsy Devices Market by Technology, Product Type, Procedure Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，支氣管鏡切片檢查設備市場價值將達到 8.2215 億美元，到 2026 年將成長至 8.8488 億美元，到 2032 年將達到 14.1304 億美元，年複合成長率為 8.04%。

主要市場統計數據
基準年 2025 8.2215億美元
預計年份：2026年 8.8488億美元
預測年份 2032 141304億美元
複合年成長率 (%) 8.04%

本節提供清晰且基於臨床的介紹，概述了支氣管鏡切片檢查裝置的發展歷程、其臨床證據以及影響其在臨床實踐中實施的操作因素。

支氣管切片檢查設備融合了呼吸內科、腫瘤科和介入內視鏡技術，使臨床醫生能夠更精準地獲取胸腔病變，同時最大限度地減少患者併發症。近年來，影像、導航和設備小型化技術的進步拓展了診斷範圍，使其涵蓋肺部周邊區域並最佳化了縱隔評估。這催生了新的臨床工作流程，並促進了呼吸科醫生、胸腔外科醫生和介入放射科醫生之間的跨學科合作。在此背景下，從設備製造商到醫院採購團隊等相關人員都需要清晰且基於臨床的視角，了解不斷發展的技術趨勢、操作流程以及推動技術應用的關鍵因素，從而指南策略規劃。

本文簡要概述了由導航、分散式和整合式臨床工作流程驅動的、正在重塑支氣管鏡切片檢查設備格局的關鍵變革性變化。

由於技術融合、操作流程分散化以及臨床對微創診斷途徑日益成長的需求，支氣管鏡切片檢查器械領域正經歷變革性的轉變。將即時成像與電磁或虛擬引導結合的導航技術，已將支氣管鏡平台的觸及範圍擴展至以往只能透過經胸途徑到達的肺週組織。同時，內視鏡光學系統、器械通道設計和切片檢查器械的改進，提高了診斷準確性並降低了併發症率。因此，臨床醫師信心倍增，多專業腫瘤會診中的轉診模式也正在改變。

分析 2025 年美國實施的累積關稅對支氣管鏡切片檢查設備的供應鏈、價格趨勢和採購方式的連鎖反應。

關稅調整和貿易政策措施將對醫療設備（包括支氣管鏡切片檢查平台和耗材）供應鏈的經濟效益、定價策略和採購決策產生重大影響。 2025年，美國實施的累積關稅調整對某些類別的醫療設備進口加徵了額外關稅，迫使製造商和經銷商重新評估其籌資策略和服務交付成本模式。對於依賴跨境零件採購的公司而言，這些措施促使它們更加重視近岸外包、供應商整合以及重新談判貿易條款，以維持利潤率並與主要客戶保持價格競爭力。

從細緻入微、基於細分的觀點，揭示技術、產品架構、臨床應用、最終用戶畫像和流程目標如何影響採用和價值獲取。

細分分析揭示了支氣管切片檢查設備在應用路徑和價值創造需求方面的差異，這些差異體現在核心技術、產品類型、應用、最終用戶和手術類型等多個維度上。在技​​術層面，臨床計畫對凸陣探頭EBUS、電磁導航和徑向EBUS平台在影像解析度、導航精度和手術效率方面的優劣進行了評估，每種模式都適用於不同的應用情境和操作者的專業程度。基於產品類型，設備的選擇受手術複雜性和醫療機構的處理能力的影響。單通道設備因其簡化診斷流程而更受青睞，而雙通道設備則因其治療的多樣性而備受青睞。超細設備能夠到達遠端周邊病變，而這些病變通常需要經皮才能到達。

區域洞察框架，比較美洲、歐洲、中東和非洲以及亞太地區的臨床實施模式、法規環境和商業性實施重點。

區域趨勢正在影響美洲、歐洲、中東和非洲以及亞太地區的臨床實踐模式、監管路徑和商業性策略，為支氣管鏡切片檢查器械領域的相關人員帶來不同的機會和實施風險。在美洲，成熟的介入呼吸系統計畫和綜合癌症中心支持早期採用先進的導航技術以及診斷和治療相結合的程序。同時，私人保險公司模式和大規模醫院網路則促使人們更加關注可驗證的手術效率和全面的診療路徑。該地區的採購週期往往重視臨床療效的比較證據、報銷相容性以及完善的上市後監測。

這份競爭情報概述重點介紹了成熟企業、專家創新者和策略夥伴關係關係如何塑造產品差異化、臨床檢驗和商業化。

支氣管鏡切片檢查設備市場的競爭動態是由傳統內視鏡製造商、專業導航設備供應商以及雄心勃勃的醫療技術Start-Ups共同推動的，這些新創公司致力於在成像、軟體和耗材設計方面進行創新。成熟企業通常利用其已建立的臨床關係、全球服務網路和豐富的產品系列，提供能夠提高手術效率和提供全生命週期支援的整合解決方案。新參與企業和細分市場參與者則傾向於透過提供特定的效能優勢來展開競爭，例如更遠的外周照射距離、更簡化的使用者介面或低成本的一次性耗材，這些優勢有可能在特定專案中取代傳統的操作流程。

為銷售、臨床和價值鏈領導者提供切實可行的策略建議，以加速產品推廣、確保基於價值的合約並降低業務風險。

產業領導者必須採取平衡的策略，將臨床證據的累積、供應鏈的韌性以及與相關人員利益相符的商業模式相結合，以確保支氣管鏡切片檢查設備的持續應用。首先，應優先進行前瞻性臨床試驗和真實世界證據（REW）研究，以證明其在縱隔分期和周邊病變取樣等關鍵適應症中具有相對較高的安全性和診斷性能。與相關人員利益相符的報銷證據將有助於在預算緊張的環境下加速設備的應用。其次，應透過供應商多元化、區域組裝方案和庫存最佳化來提高供應鏈的柔軟性，同時降低關稅和地緣政治風險，並保持價格競爭力以及快速的服務反應。

透過採用高度透明的調查方法，結合與臨床醫生的訪談、與供應商的諮詢、文獻綜述和供應鏈映射，我們能夠從多個角度檢驗見解，並證明其實際適用性。

本分析的調查方法結合了與臨床和商業相關人員的直接對話、對監管和臨床文獻的系統性回顧以及定性供應鏈分析，以確保對支氣管鏡切片檢查器械生態系統的全面了解。關鍵資訊來源包括對介入性肺科醫生、胸腔外科醫生、醫院採購經理和醫療設備工程專家的深入訪談，這些訪談揭示了實際的手術流程、器械偏好和培訓需求。除上述對話外，還與器械開發商和銷售合作夥伴進行了磋商，以了解產品藍圖、商業化挑戰和生產方面的考慮。

簡潔扼要的結論整合了臨床創新、營運韌性和實證商業化如何共同作用，從而決定支氣管鏡切片檢查設備的長期價值創造。

簡而言之，支氣管切片檢查設備正朝著提高臨床準確性、分散式操作流程和數據驅動的整合式工作流程方向發展，所有這些都在擴大其在現代胸腔外科醫學中的作用。導航精度、超薄設備和多通道多功能性等技術差異將繼續決定其在中心、縱隔和周邊適應症的臨床適用性。同時，商業性成功將取決於可靠的臨床證據、能夠抵禦關稅和貿易波動的靈活供應鏈，以及能夠反映從門診診所到大規模醫院系統等終端用戶多樣化經濟狀況的經營模式。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 支氣管鏡切片檢查設備市場：依技術分類

  • 凸陣探頭 EBUS
  • 電磁導航
  • 徑向 EBUS

第9章 支氣管鏡切片檢查設備市場：依產品類型分類

  • 雙通道設備
  • 單通道元件
  • 超薄設備

第10章 支氣管鏡切片檢查設備市場（依手術類型分類）

  • 診斷性切片檢查
  • 治療性介入

第11章 支氣管鏡切片檢查設備市場：按應用領域分類

  • 中央病變的診斷
  • 縱膈分期
    • 常規經支氣管針吸切片術
    • EBUS引導下經支氣管針吸切片手術
  • 周邊性病變的診斷
    • 無需導航的直接切片檢查
    • 電磁感應切片檢查
    • 虛擬支氣管鏡導航

第12章 支氣管鏡切片檢查設備市場：依最終用戶分類

  • 門診手術中心
    • 公司所有權
    • 醫生所有
  • 醫院手術室
    • 私立醫院
    • 公立醫院
  • 專科癌症中心

第13章 支氣管鏡切片檢查器械市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 支氣管鏡切片檢查器械市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 支氣管鏡切片檢查器械市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國支氣管鏡切片檢查設備市場

第17章：中國支氣管鏡切片檢查器械市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ambu A/S
  • Becton, Dickinson, and Company
  • Body Vision Medical Inc.
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Group Incorporated
  • Erbe Elektromedizin GmbH
  • FUJIFILM Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • Medi-Globe GmbH
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Micro-Tech（Nanjing）Co., Ltd
  • Olympus Corporation
  • Richard Wolf GmbH
  • Shanghai Aohua Photoelectricity Endoscope Co.,Ltd.
  • Teleflex Incorporated
Product Code: MRR-C92ADB4B7664

The Bronchoscopic Biopsy Devices Market was valued at USD 822.15 million in 2025 and is projected to grow to USD 884.88 million in 2026, with a CAGR of 8.04%, reaching USD 1,413.04 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 822.15 million
Estimated Year [2026] USD 884.88 million
Forecast Year [2032] USD 1,413.04 million
CAGR (%) 8.04%

A clear and clinically grounded introduction that frames bronchoscopic biopsy device evolution, clinical rationale, and the operational drivers that shape adoption across healthcare settings

Bronchoscopic biopsy devices sit at the intersection of pulmonology, oncology, and interventional endoscopy, enabling clinicians to access thoracic lesions with increasing precision while minimizing patient morbidity. Recent advances in imaging, navigation, and device miniaturization have expanded diagnostic reach into peripheral lung territories and optimized mediastinal evaluation, creating new clinical workflows and cross-disciplinary collaboration between pulmonologists, thoracic surgeons, and interventional radiologists. Against this backdrop, stakeholders from device manufacturers to hospital procurement teams require a clear, clinically grounded synthesis of the evolving technology landscape, procedural pathways, and adoption enablers to inform strategy.

This introduction synthesizes the clinical rationale for bronchoscopic biopsy, highlights key device classes and their functional distinctions, and outlines the principal adoption drivers in contemporary practice. It also frames how reimbursement dynamics, procedure setting diversification, and clinician training intersect with technological evolution to shape deployment. By setting this context, readers will be positioned to understand downstream analyses of market forces, regulatory impacts, segmentation nuances, and recommended strategic responses that follow in the report.

A concise synthesis of the key transformative shifts reshaping the bronchoscopic biopsy device landscape driven by navigation, decentralization, and integrated clinical workflows

The landscape for bronchoscopic biopsy devices is undergoing transformative shifts driven by technological convergence, procedural decentralization, and heightened clinical demand for less invasive diagnostic pathways. Navigation technologies that integrate real-time imaging with electromagnetic or virtual guidance have extended the reach of bronchoscopic platforms into peripheral lung tissue previously accessible primarily by transthoracic approaches. Concurrent improvements in endoscope optics, tool channel engineering, and sampling instruments have improved diagnostic yield and reduced complication rates, which in turn have led to broader clinician confidence and evolving referral patterns within multidisciplinary tumor boards.

At the same time, the procedural setting is diversifying: ambulatory procedural centers and specialized cancer units are emerging as viable venues for selected bronchoscopic procedures, supported by streamlined sedation protocols and shorter recovery workflows. This shift is accompanied by growing interest in combined diagnostic and therapeutic pathways that pair biopsy with localized interventions or molecular sampling to inform precision oncology. Additionally, data and software are becoming central components of the value proposition; integration of navigation outputs with electronic health records and pathology workflows enhances longitudinal care coordination and supports value-based contracting. Taken together, these shifts are creating new imperatives for device makers, health systems, and clinical leaders to reassess product portfolios, training programs, and partnerships in order to capture evolving clinical pathways and institutional priorities.

An analysis of how the cumulative United States tariffs enacted in 2025 reverberated through supply chains, pricing dynamics, and procurement approaches for bronchoscopic biopsy devices

Tariff changes and trade policy actions can exert a material influence on the supply chain economics, pricing strategies, and procurement decisions for medical devices, including bronchoscopic biopsy platforms and consumables. In 2025, cumulative tariff adjustments enacted by the United States imposed added duties on select categories of medical device imports, prompting manufacturers and distributors to re-evaluate sourcing strategies and cost-to-serve models. For companies relying on cross-border component supply, these measures intensified focus on nearshoring, supplier consolidation, and renegotiation of commercial terms to maintain margin and competitive pricing in key accounts.

Operationally, healthcare providers experienced heightened procurement diligence as hospital purchasing teams and group purchasing organizations examined total landed costs, incorporating tariff-related price movements into capital planning and consumables budgeting. In response, several suppliers accelerated localization of assembly, increased inventory buffers at domestic distribution hubs, and introduced modular product configurations to reduce dependence on tariff-exposed subassemblies. From a strategic perspective, the tariffs catalyzed contractual innovations including longer-term price agreements, value-sharing models tied to outcomes, and expanded service offerings to preserve adoption momentum amid tighter budgetary constraints. Looking ahead, the cumulative effect of these measures underscores the need for manufacturers and health systems to maintain flexible supply networks, scenario-based pricing strategies, and transparent cost communication that align with institutional procurement policies and clinical imperatives.

A granular segmentation-driven perspective that clarifies how technology, product architecture, clinical application, end-user profiles, and procedure objectives shape adoption and value capture

Segmentation analysis reveals differentiated adoption pathways and value imperatives across the core technology, product, application, end user, and procedure type dimensions of bronchoscopic biopsy devices. Based on technology, clinical programs evaluate trade-offs among convex probe EBUS, electromagnetic navigation, and radial EBUS platforms in terms of imaging fidelity, navigation accuracy, and procedural ergonomics, with each modality aligning to distinct diagnostic use cases and operator expertise. Based on product type, device selection is influenced by procedural complexity and institutional throughput, with single channel devices preferred for streamlined diagnostic workflows, double channel devices valued for therapeutic versatility, and ultrathin devices enabling access to distal peripheral lesions that would otherwise require percutaneous approaches.

Based on application, clinical protocols and purchasing choices reflect the needs of central lesion diagnosis, mediastinal staging, and peripheral lesion diagnosis; within mediastinal staging clinicians further differentiate between conventional TBNA and EBUS-guided TBNA for procedural accuracy and sampling yield, while peripheral lesion diagnosis pathways bifurcate into direct sampling without navigation, electromagnetic navigated sampling, and virtual bronchoscopy navigation based on lesion location and institutional imaging capabilities. Based on end user, adoption dynamics are shaped by the operational profile of ambulatory surgical centers, hospital operating rooms, and specialized cancer centers, with ambulatory surgical centers further segmented into corporate owned and physician owned models, and hospital operating rooms divided between private and public hospital systems that have distinct procurement cycles, credentialing practices, and throughput expectations. Based on procedure type, device configurations and service bundles are tailored to whether the primary objective is diagnostic biopsy or therapeutic intervention, influencing consumable design, sterilization workflows, and perioperative support. By synthesizing these segmentation lenses, stakeholders can prioritize product development, training, and commercial strategies that are tightly aligned to the clinical, operational, and economic needs of target customer cohorts.

A regional insight framework that contrasts clinical adoption models, regulatory environments, and commercial execution priorities across the Americas, EMEA, and Asia-Pacific

Regional dynamics influence clinical practice patterns, regulatory pathways, and commercial approaches across the Americas, Europe Middle East & Africa, and Asia-Pacific, producing distinct opportunity sets and execution risks for bronchoscopic biopsy device stakeholders. In the Americas, established interventional pulmonology programs and integrated cancer centers support early adoption of advanced navigation and combined diagnostic-therapeutic procedures, while private payor models and large hospital networks drive emphasis on demonstrable procedural efficiency and bundled care pathways. Procurement cycles in this region often reward evidence of comparative clinical benefit, reimbursement alignment, and robust post-market surveillance.

Across Europe, the Middle East, and Africa, market heterogeneity is pronounced: western European centers prioritize guideline-driven adoption, health-technology assessments, and centralized purchasing, whereas emerging markets in the region may emphasize cost-effective solutions and partnerships that facilitate local training. Regulatory nuances and reimbursement fragmentation necessitate adaptive go-to-market strategies that balance clinical evidence generation with pragmatic distribution models. In the Asia-Pacific region, rapid expansion of cancer care infrastructure, rising access to advanced imaging, and pronounced interest in minimally invasive diagnostics accelerate demand for navigation-enabled platforms, yet suppliers must navigate diverse regulatory environments, variable procurement frameworks, and a spectrum of hospital capabilities. Collectively, these regional insights underscore the importance of tailored market entry plans, nuanced value propositions, and investment in clinician education to support sustainable uptake across geographies.

A competitive intelligence overview highlighting how incumbents, specialized innovators, and strategic partnerships are shaping product differentiation, clinical validation, and commercialization

Competitive dynamics across bronchoscopic biopsy devices are driven by a combination of legacy endoscopy manufacturers, specialized navigation providers, and ambitious medical technology startups that bring focused innovations in imaging, software, and consumable design. Incumbent firms typically leverage established clinical relationships, global service networks, and broad product portfolios to offer integrated solutions that address procedure efficiency and lifecycle support. Newer entrants and niche players often compete on the basis of targeted performance advantages-such as enhanced peripheral reach, streamlined user interfaces, or lower-cost disposables-that can displace legacy workflows in specialized programs.

Partnerships and distribution alliances are common strategic levers, particularly when firms seek rapid access to new geographies or complementary technology stacks. Licensing arrangements for navigation software, co-development partnerships with imaging providers, and joint training programs with academic centers are frequent pathways to accelerate clinical validation and adoption. Additionally, as hospitals and ambulatory centers increasingly evaluate total cost of ownership, companies that offer bundled service contracts, outcome-focused value propositions, and flexible financing will often find greater receptivity. For investors and corporate strategists, the competitive picture suggests an environment where product differentiation, evidence generation, and scalable commercial infrastructure determine the leaders of the next adoption cycle.

Actionable strategic recommendations for commercial, clinical, and supply chain leaders to accelerate adoption, secure value-based contracting, and reduce operational exposure

Industry leaders must pursue a balanced strategy that combines clinical evidence generation, supply chain resilience, and stakeholder-aligned commercial models to secure sustained adoption of bronchoscopic biopsy devices. First, prioritize prospective clinical studies and real-world evidence initiatives that demonstrate comparative safety and diagnostic performance across key applications such as mediastinal staging and peripheral lesion sampling; evidence tailored to reimbursement stakeholders will accelerate conversion in budget-constrained environments. Second, enhance supply chain flexibility through supplier diversification, regional assembly options, and inventory optimization to mitigate tariff and geopolitical exposure while preserving competitive pricing and service responsiveness.

Third, invest in comprehensive clinician training and credentialing programs that reduce procedural variability and increase repeatable outcomes; immersive simulation, proctoring networks, and integrated digital training tools can shorten the learning curve and increase institutional confidence. Fourth, design commercial bundles that reflect end-user economics-combining device hardware, consumables, software support, and outcome-linked service agreements-to align incentives with hospital and ambulatory center priorities. Finally, pursue selective partnerships with imaging providers, pathology networks, and IT integrators to create seamless clinical workflows that demonstrate measurable improvements in patient throughput, diagnostic timelines, and multidisciplinary decision-making. Executed together, these recommendations will position organizations to capture demand responsibly while reinforcing clinical value and operational scalability.

A transparent methodology blending clinician interviews, supplier consultations, literature review, and supply chain mapping to triangulate insights and validate practical applicability

The research methodology underpinning this analysis blended primary engagement with clinical and commercial stakeholders, systematic review of regulatory and clinical literature, and qualitative supply chain mapping to ensure a holistic understanding of the bronchoscopic biopsy device ecosystem. Primary inputs included in-depth interviews with interventional pulmonologists, thoracic surgeons, hospital procurement leaders, and biomedical engineering specialists, which illuminated real-world procedural workflows, device preferences, and training needs. These conversations were complemented by consultations with device developers and distribution partners to capture product roadmaps, commercialization challenges, and manufacturing considerations.

Secondary analysis incorporated peer-reviewed clinical studies, regulatory filings, procedural guidelines, and relevant industry reports to contextualize device performance, safety profiles, and adoption drivers. Supply chain and tariff impacts were assessed through import-export data, customs classifications, and documented corporate responses to trade measures, enabling scenario-based interpretation of operational risks. Throughout, findings were triangulated to validate themes and ensure consistency across data sources, with particular attention to clinical credibility and applicability for decision-makers in manufacturing, hospital leadership, and investment communities.

A concise conclusion synthesizing how clinical innovation, operational resilience, and evidence-driven commercialization collectively determine long-term value capture in bronchoscopic biopsy devices

In sum, bronchoscopic biopsy devices are converging toward greater clinical precision, procedural decentralization, and integrated data-enabled workflows that collectively expand their role in modern thoracic care. Technology differentiation-whether through navigation fidelity, ultrathin device engineering, or multi-channel versatility-will continue to determine clinical fit across central, mediastinal, and peripheral indications. Meanwhile, commercial success will hinge on credible clinical evidence, adaptable supply chains that withstand tariff and trade volatility, and commercial models that reflect the economics of diverse end users from ambulatory centers to large hospital systems.

As stakeholders prepare for the next phase of adoption, they should align product development with real-world procedural needs, invest in clinician competency programs, and pursue partnerships that enhance the end-to-end care pathway. Organizations that proactively address evidence generation, operational resilience, and customer-centric commercialization will be best positioned to capture long-term clinical and commercial value in this evolving landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bronchoscopic Biopsy Devices Market, by Technology

  • 8.1. Convex Probe EBUS
  • 8.2. Electromagnetic Navigation
  • 8.3. Radial EBUS

9. Bronchoscopic Biopsy Devices Market, by Product Type

  • 9.1. Double Channel Devices
  • 9.2. Single Channel Devices
  • 9.3. Ultrathin Devices

10. Bronchoscopic Biopsy Devices Market, by Procedure Type

  • 10.1. Diagnostic Biopsy
  • 10.2. Therapeutic Intervention

11. Bronchoscopic Biopsy Devices Market, by Application

  • 11.1. Central Lesion Diagnosis
  • 11.2. Mediastinal Staging
    • 11.2.1. Conventional Tbna
    • 11.2.2. Ebus Guided Tbna
  • 11.3. Peripheral Lesion Diagnosis
    • 11.3.1. Direct Sampling Without Navigation
    • 11.3.2. Electromagnetic Navigated Sampling
    • 11.3.3. Virtual Bronchoscopy Navigation

12. Bronchoscopic Biopsy Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
    • 12.1.1. Corporate Owned
    • 12.1.2. Physician Owned
  • 12.2. Hospital Operating Rooms
    • 12.2.1. Private Hospitals
    • 12.2.2. Public Hospitals
  • 12.3. Specialized Cancer Centers

13. Bronchoscopic Biopsy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bronchoscopic Biopsy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bronchoscopic Biopsy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Bronchoscopic Biopsy Devices Market

17. China Bronchoscopic Biopsy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Ambu A/S
  • 18.6. Becton, Dickinson, and Company
  • 18.7. Body Vision Medical Inc.
  • 18.8. Boston Scientific Corporation
  • 18.9. CONMED Corporation
  • 18.10. Cook Group Incorporated
  • 18.11. Erbe Elektromedizin GmbH
  • 18.12. FUJIFILM Holdings Corporation
  • 18.13. Johnson & Johnson Services, Inc.
  • 18.14. KARL STORZ SE & Co. KG
  • 18.15. Medi-Globe GmbH
  • 18.16. Medtronic PLC
  • 18.17. Merit Medical Systems, Inc.
  • 18.18. Micro-Tech (Nanjing) Co., Ltd
  • 18.19. Olympus Corporation
  • 18.20. Richard Wolf GmbH
  • 18.21. Shanghai Aohua Photoelectricity Endoscope Co.,Ltd.
  • 18.22. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVEX PROBE EBUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVEX PROBE EBUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVEX PROBE EBUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY RADIAL EBUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY RADIAL EBUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY RADIAL EBUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DOUBLE CHANNEL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DOUBLE CHANNEL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DOUBLE CHANNEL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SINGLE CHANNEL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SINGLE CHANNEL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SINGLE CHANNEL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ULTRATHIN DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ULTRATHIN DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ULTRATHIN DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY THERAPEUTIC INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY THERAPEUTIC INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY THERAPEUTIC INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CENTRAL LESION DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CENTRAL LESION DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CENTRAL LESION DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVENTIONAL TBNA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVENTIONAL TBNA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CONVENTIONAL TBNA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY EBUS GUIDED TBNA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY EBUS GUIDED TBNA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY EBUS GUIDED TBNA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIRECT SAMPLING WITHOUT NAVIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIRECT SAMPLING WITHOUT NAVIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY DIRECT SAMPLING WITHOUT NAVIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATED SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATED SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY ELECTROMAGNETIC NAVIGATED SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY VIRTUAL BRONCHOSCOPY NAVIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY VIRTUAL BRONCHOSCOPY NAVIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY VIRTUAL BRONCHOSCOPY NAVIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CORPORATE OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CORPORATE OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY CORPORATE OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PHYSICIAN OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PHYSICIAN OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PHYSICIAN OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SPECIALIZED CANCER CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 178. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 181. GCC BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 202. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 208. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 209. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 211. G7 BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 212. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 218. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 219. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 221. NATO BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA BRONCHOSCOPIC BIOPSY DEVICES MARKET SIZE, BY HOSPITAL OPERATING ROOMS, 2018-2032 (USD MILLION)